Treating neural conditions resulting from spinal cord...

Details Treating neural conditions resulting from spinal cord... Treating neural conditions resulting from spinal cord...

2006-11-14

2006-11-14

Hui, San-ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C514S649000, C514S651000, C514S653000, C514S650000

Reexamination Certificate

active

07135497

ABSTRACT:
β2-agonists, such as clenbuterol and salbutamol can enhance the recovery of locomotive function and/or neuromuscular strength following spinal cord injuries or as a result of degenerative neural conditions such as Mnd. Pharmacological compositions for treating spinal cord injuries and degenerative neural conditions are also provided.

REFERENCES:
patent: 5281607 (1994-01-01), Stone et al.
patent: WO99/09966 (1999-03-01), None
Zeman et al., Experimental neurology 1999; 159:267-273.
Sayers et al., Society for Neuroscience Abstracts 1998; 24: abstract 125.2.
Zeman et al., Experimental Neurology, 1999;159:267-273.
Murphy et al., Arch. Phys. Med. Rehabil., 1999;80(10):1264-1267.
Vaidyanathan et al., Spinal Cord, 1996; 34: 691-695.

Affiliated with

Also associated with

Rating

Treating neural conditions resulting from spinal cord... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating neural conditions resulting from spinal cord..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating neural conditions resulting from spinal cord... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3647667